Alcedis

Alcedis

Giessen, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Alcedis is a private, revenue-generating company founded in 1999, headquartered in Giessen, Germany. It operates as a hybrid entity, offering comprehensive CRO services across multiple therapeutic areas alongside its proprietary 'Alcedis Platforms' technology suite for data integration and management in clinical trials. The company positions itself at the intersection of traditional clinical operations and digital innovation, utilizing AI solutions like 'Meteor' and 'AI-Soultions' to enhance data quality and study efficiency. Its business model is built on providing integrated service and software solutions to biotech and pharmaceutical sponsors.

CardiologyOncologyRespiratoryDiabetesNeurologyOphthalmology

Technology Platform

Alcedis Platforms™: A proprietary technology suite for multi-channel data integration in clinical trials, featuring customizable eCRFs, mobile apps, plugins, big data interfaces, and AI solutions (including 'Meteor') aimed at improving data quality and study efficiency.

Opportunities

The global shift towards digital and decentralized clinical trials creates strong demand for integrated technology-service providers.
The growing need for Real-World Evidence (RWE) generation and the expansion of the biotech sector, which often requires full-service external partners, present significant growth avenues for Alcedis's model.

Risk Factors

Alcedis faces intense competition from large global CROs and pure-play tech vendors.
Its integrated model carries execution risk, and the practical, regulated application of its AI solutions must overcome industry hype and scrutiny.
Revenue is also dependent on the overall health of biopharma R&D spending.

Competitive Landscape

Alcedis competes in a crowded market against large, full-service CROs with technology arms (e.g., IQVIA, Parexel) and dominant standalone clinical trial software vendors (e.g., Veeva Vault, Medidata Rave). Its differentiation lies in its deep integration of services and proprietary platform, positioning it as a hybrid solution for sponsors, particularly in the biotech segment.